LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 220 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $448,381 | -33.0% | 7,483 | -19.4% | 0.01% | -40.0% |
| Q2 2023 | $669,232 | +114.3% | 9,282 | +118.7% | 0.02% | +87.5% |
| Q1 2023 | $312,262 | -20.1% | 4,245 | -6.6% | 0.01% | -33.3% |
| Q3 2022 | $391,000 | +39.6% | 4,543 | +44.5% | 0.01% | +33.3% |
| Q2 2022 | $280,000 | -45.6% | 3,143 | -31.4% | 0.01% | -43.8% |
| Q1 2022 | $515,000 | -3.6% | 4,580 | +32.4% | 0.02% | -5.9% |
| Q4 2021 | $534,000 | +59.4% | 3,458 | +43.7% | 0.02% | +21.4% |
| Q3 2021 | $335,000 | -0.3% | 2,407 | -6.0% | 0.01% | 0.0% |
| Q2 2021 | $336,000 | +8.4% | 2,562 | +25.8% | 0.01% | 0.0% |
| Q1 2021 | $310,000 | -16.0% | 2,036 | -45.2% | 0.01% | +16.7% |
| Q4 2020 | $369,000 | +43.6% | 3,715 | +50.5% | 0.01% | +140.0% |
| Q4 2019 | $257,000 | +21.2% | 2,468 | +16.1% | 0.01% | +25.0% |
| Q3 2019 | $212,000 | -97.1% | 2,125 | -96.7% | 0.00% | -96.6% |
| Q2 2019 | $7,382,000 | +130.9% | 64,671 | +154.3% | 0.12% | +151.1% |
| Q1 2019 | $3,197,000 | +42.3% | 25,435 | +53.6% | 0.05% | +34.3% |
| Q4 2018 | $2,247,000 | -70.6% | 16,557 | -40.5% | 0.04% | -66.7% |
| Q3 2018 | $7,634,000 | +163.3% | 27,811 | +98.8% | 0.10% | +150.0% |
| Q2 2018 | $2,899,000 | +7.6% | 13,991 | -14.2% | 0.04% | +10.5% |
| Q1 2018 | $2,694,000 | -62.2% | 16,310 | -68.7% | 0.04% | -63.5% |
| Q4 2017 | $7,134,000 | -42.8% | 52,100 | -55.8% | 0.10% | -34.2% |
| Q1 2017 | $12,463,000 | +261.1% | 117,749 | +246.7% | 0.16% | +259.1% |
| Q4 2016 | $3,451,000 | -11.6% | 33,965 | -11.2% | 0.04% | -13.7% |
| Q3 2016 | $3,902,000 | -54.5% | 38,231 | -46.8% | 0.05% | -50.5% |
| Q2 2016 | $8,572,000 | +266.8% | 71,870 | +229.3% | 0.10% | +296.2% |
| Q1 2016 | $2,337,000 | +1068.5% | 21,822 | +479.4% | 0.03% | +1200.0% |
| Q4 2014 | $200,000 | -99.2% | 3,766 | -99.3% | 0.00% | -99.2% |
| Q3 2014 | $25,941,000 | +650.4% | 552,053 | +894.8% | 0.26% | +500.0% |
| Q2 2014 | $3,457,000 | +376.2% | 55,492 | +302.0% | 0.04% | +152.9% |
| Q4 2013 | $726,000 | +172.9% | 13,803 | +125.0% | 0.02% | +88.9% |
| Q3 2013 | $266,000 | – | 6,136 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VILLERE ST DENIS J & CO LLC | 518,988 | $80,162,000 | 4.60% |
| Knott David M Jr | 75,000 | $11,585,000 | 3.93% |
| Orchard Capital Management, LLC | 68,596 | $10,595,000 | 3.11% |
| Chicago Capital, LLC | 436,456 | $67,415,000 | 2.51% |
| RICE HALL JAMES & ASSOCIATES, LLC | 347,699 | $53,706,000 | 1.91% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 85,990 | $13,282,000 | 1.46% |
| Smith, Graham & Co., Investment Advisors, LP | 87,392 | $13,499,000 | 1.34% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 44,754 | $6,913,000 | 1.12% |
| WOODSTOCK CORP | 68,666 | $10,606,000 | 1.11% |
| Stephens Investment Management Group LLC | 411,359 | $63,539,000 | 0.82% |